Hereditary haemochromatosis (HH) type 1
Conditions
Interventions
None listed
Sponsors
Novo Nordisk A/S
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Countries
Austria
Outcome results
None listed